SCHEMBL3556233

SCHEMBL3556233

O=C(O)[C@@H]1c2ccccc2-c2c(-c3nc4cnccc4[nH]3)cccc21

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 5/20 0.54
KDM4E B2RXH2 2/20 0.44
RAB9A P51151 1/20 0.44
PDE5A O76074 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
FGFR1 P11362 2/20 0.38
FLT1 P17948 2/20 0.38
METAP2 P50579 1/20 0.37
NPC1 O15118 1/20 0.36
GBA1 P04062 1/20 0.36
F7 P08709 1/20 0.36
KDM4C Q9H3R0 1/20 0.36
LDHA P00338 1/20 0.35
EPHX2 P34913 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3556234 1.00 HSP90AB1 (0.54) HSP90AB1KDM4ERAB9APDE5ASMN1; SMN2
Hydrochloric Acid SCHEMBL27715985 0.99 HSP90AB1 (0.53) HSP90AB1KDM4ERAB9APDE5ASMN1; SMN2
SCHEMBL3561942 0.91 HSP90AB1 (0.65) HSP90AB1KDM4ERAB9APDE5ASMN1; SMN2
SCHEMBL3561945 0.91 HSP90AB1 (0.65) HSP90AB1KDM4ERAB9APDE5ASMN1; SMN2
SCHEMBL12431147 0.83 HSP90AB1 (0.53) HSP90AB1KDM4ERAB9APDE5ASMN1; SMN2
SCHEMBL12430888 0.83 HSP90AB1 (0.52) HSP90AB1KDM4ERAB9ASMN1; SMN2
SCHEMBL2312667 0.81 HSP90AB1 (0.50) HSP90AB1KDM4ERAB9APDE5ASMN1; SMN2
SCHEMBL13437139 0.81 HSP90AB1 (0.50) HSP90AB1KDM4ERAB9APDE5ASMN1; SMN2
SCHEMBL2315006 0.81 HSP90AB1 (0.50) HSP90AB1KDM4ERAB9APDE5ASMN1; SMN2
SCHEMBL27263584 0.81 HSP90AB1 (0.53) HSP90AB1KDM4ERAB9APDE5ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7674795-B2 Fluorene derivatives, composition containing said derivatives and the use thereof AVENTIS PHARMA SA (FR) 2010-03-09 US disclosed
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof AVENTIS PHARMA S.A. (FR) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153837-A1 Novel Fluorene Derivatives, Composition Containing Said Derivatives and the Use Thereof HSP90B1, HSP90AB1, HSP90AA1 HSP90AB1 2/4885KDM4E 3419/4885RAB9A 1012/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.